Voir la vidéoWatch the full video
Events

On March 1st, Delpharm finalized the acquisition from Novartis of its Boucherville sterile plant located in Canada.

A leading CDMO

Drug developer and Contract manufacturer. With its 19 plants, Delpharm is in the Top 5 CDMOs Worldwide.

Dosage forms

Delpharm produces most dosage forms; non-sterile and sterile liquids, solids, semi-solids and biotech.

Development & Regulation

A team of experts to support new pharmaceutical products.

100
100

Management ownership 100%

950
950

Turnover M€

5
5

World Top 5

6000
6000

Headcount

Serialization
Major on going project for Delpharm since 2015, all Delpharm plants already shipping serialized products.
Read more...
Regulatory affairs
A full team dedicated to support you in the long term or for emergency needs.
Read more...
Soft gel capsules
Delpharm now offers the manufacturing and packaging of soft gel capsules in Evreux plant and high potent soft gel capsules in Poznań.
Freeze-drying
New dosage form now available at Delpharm plants.

Customer references

Bayer
Merck
Genfit
Eisai
GlaxoSmithKline
Bracco
Sanionia
Cooper
Daiichi-Sankyo
Biocodex
Zoetis
Meda
HRA Pharma
Aurobindo
Takeda
Urgo
Teva
Biogaran
Novartis
OM Pharma
Mylan
Aguettant
LFB
Zentiva
Sandoz
Boehringer Indelheim
Sanofi
Servier